Advertisement

Document › Details
Grifols S.A.. (7/28/17). "Press Release: Grifols Increases Its Revenues by 12.3% to EUR 2,192 Million Driven by Growth of Its Main Divisions". Barcelona.
![]() |
Organisation | Grifols S.A. |
Group | Grifols (Group) | |
Organisation 2 | GigaGen Inc. | |
![]() |
Product | plasma protein |
Product 2 | diagnostics (medical/biological) | |
![]() |
Index term | GigaGen–Grifols: investment, acquisition of 44% stake in GigaGen Inc for $35m in cash by Grifols |
Original document
accessed by [iito] on 2017-07-31
Record changed: 2023-06-05 |
Advertisement

More documents for Grifols (Group)
- [1] Biotest AG. (4/25/22). "Press Release: Grifols Acquires Majority of Voting Rights in Biotest". Dreieich....
- [2] Grifols S.A.. (9/17/21). "Press Release: Grifols Acquires Tiancheng Pharmaceutical Holdings, the Largest Shareholder of Biotest, to Increase Patients’ Access to Plasma Therapies". Barcelona....
- [3] Grifols S.A.. (11/24/20). "Press Release: Strategic Alliance between Grifols and the Egyptian Government to Boost Plasma-derived Medicines Self-sufficiency in the Middle East and Africa". Barcelona....
- [4] Grifols S.A.. (9/7/20). "Press Release: Grifols to Acquire Alkahest to Enhance Discovery Research and Development". Barcelona & San Carlos, CA....
- [5] Grifols S.A.. (2/18/20). "Press Release: Grifols and the Public Investment Fund of Saudi Arabia Taking Steps to Boost Plasma Medicines Self-supply in the Region". Barcelona....
- [6] Grifols S.A.. (11/13/19). "Press Release: Grifols and Shanghai RAAS Obtain Authorization for Their Strategic Alliance in China". Barcelona....
- [7] Grifols S.A.. (7/31/19). "Press Release: Grifols Increases Its Revenues by 14.3% to EUR 2,423 million, Driven by Its Strategic Growth Plan". Barcelona....
- [8] Grifols S.A.. (2/7/19). "Press Release: Grifols Receives FDA Approval for Procleix Babesia Assay for Donor Screening on Procleix Panther System". Barcelona....
- [9] Grifols S.A.. (1/23/19). "Press Release: Grifols Announces Collaboration and License Agreement with Rigel Pharmaceuticals to Commercialize Fostamatinib in Europe". Barcelona....
- [10] European Invesmtent Bank (EIB). (9/7/18). "Press Release: Investment Plan for Europe – the EIB and Grifols Sign a New Loan Agreement to Advance Research on Rare and Chronic Diseases"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Advertisement

» top